Darifenacin
These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004
62a72d3e-3c33-4f2d-b3d0-2e014f704c63
HUMAN PRESCRIPTION DRUG LABEL
Dec 1, 2022
POLYGEN PHARMACEUTICALS INC.
DUNS: 962415720
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Darifenacin Hydrobromide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Darifenacin Hydrobromide
Product Details
FDA regulatory identification and product classification information